Education
About Us
Working with TipRanks
Follow Us
Bio-Gene Technology Ltd. (AU:BGT)
ASX:BGT
Total Valuation
Bio-Gene Technology Ltd. has a market cap or net worth of AU$10.98M. The enterprise value is AU$2.54M.
Market CapAU$10.98M
Enterprise ValueAU$2.54M
Share Statistics
Bio-Gene Technology Ltd. has 305,061,100 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding305,061,100
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Bio-Gene Technology Ltd.’s return on equity (ROE) is -0.86 and return on invested capital (ROIC) is -87.02%.
Return on Equity (ROE)-0.86
Return on Assets (ROA)-0.76
Return on Invested Capital (ROIC)-87.02%
Return on Capital Employed (ROCE)-1.09
Revenue Per Employee―
Profits Per Employee―
Employee Count―
Asset Turnover<0.01
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Bio-Gene Technology Ltd. is ―. Bio-Gene Technology Ltd.’s PEG ratio is ―.
PE Ratio―
PS Ratio0.00
PB Ratio0.00
Price to Fair Value3.32
Price to FCF0.00
Price to Operating Cash Flow-1.92
PEG Ratio―
Income Statement
In the last 12 months, Bio-Gene Technology Ltd. had revenue of 18.32K and earned -2.41M in profits. Earnings per share was -0.01.
Revenue18.32K
Gross Profit-301.45K
Operating Income-3.06M
Pretax Income-3.01M
Net Income-2.41M
EBITDA-2.97M
Earnings Per Share (EPS)-0.01
Cash Flow
In the last 12 months, operating cash flow was -1.88M and capital expenditures -3.90K, giving a free cash flow of -1.88M billion.
Operating Cash Flow-1.88M
Free Cash Flow-1.88M
Free Cash Flow per Share>-0.01
Dividends & Yields
Bio-Gene Technology Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.19
52-Week Price Change-40.00%
50-Day Moving Average0.02
200-Day Moving Average0.03
Relative Strength Index (RSI)56.22
Average Volume (3m)986.28K
Important Dates
Bio-Gene Technology Ltd. upcoming earnings date is Mar 4, 2026, TBA (Confirmed).
Last Earnings DateAug 25, 2025
Next Earnings DateMar 4, 2026
Ex-Dividend Date―
Financial Position
Bio-Gene Technology Ltd. as a current ratio of 8.49, with Debt / Equity ratio of 0.00%
Current Ratio8.49
Quick Ratio8.49
Debt to Market Cap0.00
Net Debt to EBITDA0.74
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Bio-Gene Technology Ltd. has paid -604.19K in taxes.
Income Tax-604.19K
Effective Tax Rate0.20
Enterprise Valuation
Bio-Gene Technology Ltd. EV to EBITDA ratio is -2.37, with an EV/FCF ratio of -2.56.
EV to Sales385.18
EV to EBITDA-2.37
EV to Free Cash Flow-2.56
EV to Operating Cash Flow-2.56
Balance Sheet
Bio-Gene Technology Ltd. has AU$1.34M in cash and marketable securities with AU$0.00 in debt, giving a net cash position of AU$1.34M billion.
Cash & Marketable SecuritiesAU$1.34M
Total DebtAU$0.00
Net CashAU$1.34M
Net Cash Per Share<AU$0.01
Tangible Book Value Per ShareAU$0.01
Margins
Gross margin is 128484.37%, with operating margin of -16716.50%, and net profit margin of -13150.54%.
Gross Margin128484.37%
Operating Margin-16716.50%
Pretax Margin-16448.50%
Net Profit Margin-13150.54%
EBITDA Margin-16239.02%
EBIT Margin-16448.52%
Analyst Forecast
The average price target for Bio-Gene Technology Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―